Product Information
CEFIXIME 400 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $10.0915 per EA under NDC 67877058433. Its NADAC has been published 167 times since Feb 22, 2023.
Strength
400 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877058433
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CEFIXIMEApproval Type
Generic (ANDA)
FDA Application
ANDA210574On Market Since
10/12/2018
Pharmacological Classes
Price Statistics
The NADAC for CEFIXIME 400 MG CAPSULE has been published 167 times since Feb 22, 2023, and over the history we have for it it has declined 6.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.0915 per EA |
|---|---|
| All-time high | $10.7608 (Feb 14, 2024) |
| All-time low | $9.2307 (Aug 21, 2024) |
| 52-week high | $10.7437 |
| 52-week low | $9.7585 |
| Median price | $10.2387 |
| Average price | $10.1626 |
| Largest weekly change | -7.3% (Apr 17, 2024) |
| Weeks tracked | 167 |
| Tracking since | Feb 22, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFIXIME 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEFIXIME 400 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $10.0915 per EA (NDC 67877058433), effective Jun 24, 2026.
How has the price of CEFIXIME 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEFIXIME 400 MG CAPSULE has declined 6.2%. It has been tracked across 167 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for CEFIXIME 400 MG CAPSULE?
Since Feb 22, 2023, the NADAC for CEFIXIME 400 MG CAPSULE has ranged from a low of $9.2307 (Aug 21, 2024) to a high of $10.7608 (Feb 14, 2024), with a median of $10.2387 per EA.
Are there cheaper alternatives to CEFIXIME 400 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as CEFIXIME 400 MG CAPSULE, but none are currently priced below it.
Who manufactures CEFIXIME 400 MG CAPSULE?
CEFIXIME 400 MG CAPSULE (NDC 67877058433) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification